The ThinkGenetic Foundation conducts research into topics that support their mission to improve the quality of life for those living with or at risk for a genetic condition. Project partners in this research often include academic institutions, key opinion leaders in genetics, and support advocacy groups.
2020Goal: To identify individuals at risk of being affected by Hereditary Angioedema
Funding: Supporting, in part, by an Investigator Initiated Grant from Takeda Pharmaceuticals
Indirect Cost Policy: For project partners on ThinkGenetic Foundation research, our policy allows for a maximum of 10% indirect costs for each project.